13F-HR filed by Brevan Howard Capital Management LP
Brevan Howard Capital Management LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 1,006 holding rows worth $8,182,974,982.
- Accession
- 0000905148-24-000687
- Filer
- CIK 1512857
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 1,030 entries on the cover page, a total value of $8,182,974,982 stated on the cover page (in dollars after the unit check, H1), rows summing to $8,182,974,982 with VALUE read as dollars as filed, 13F file number 028-14379. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBrevan Howard Investment Products Ltd028-14381
- included managerBrevan Howard Asset Management LLP028-12590
- included managerBrevan Howard US Investment Management, LP028-16818
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMERICAN WELL CORP | 03044L105 | CL A | 21,583 | $32,159 | dollars as filed | |
| PLAYSTUDIOS INC | 72815G108 | CLASS A COM | 10,932 | $29,626 | dollars as filed | |
| ENDEAVOUR SILVER CORP | 29258Y103 | COM | 14,971 | $29,493 | dollars as filed | |
| MICROVAST HOLDINGS INC COM | 59516C106 | Stock | 17,299 | $24,219 | dollars as filed | |
| GEVO INC | 374396406 | COM PAR | 13,949 | $16,181 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 10,373 | $15,041 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000905148-24-000687 | this filing | 2024-02-14 | acceptance time not in the bulk data set |